Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Gynecology · Ovarian Dermoid Cyst

How Is an Ovarian Dermoid Cyst Treated After Menopause?

At a Glance

After menopause, a small ovarian dermoid cyst with classic benign ultrasound features and no symptoms can be monitored. Surgery is often advised for a large, growing, symptomatic, or suspicious cyst, but blood tests alone cannot rule out cancerous change.

After menopause, an ovarian dermoid cyst (also known as a mature cystic teratoma) can be managed with either careful observation or surgery. A dermoid is a type of cyst that develops from germ cells and can contain mature tissues like fat, hair, or calcium. Because these contents can look complex on an ultrasound, and because the risk of a cyst containing cancer increases slightly with age, your doctor will carefully evaluate your symptoms, your imaging results, and your overall health to recommend a tailored plan.

Why Menopause Changes the Approach

Dermoid cysts are common benign (non-cancerous) ovarian tumors. The risk of malignant transformation—where cancer, most commonly a type called squamous cell carcinoma, develops inside the cyst—is very rare overall, occurring in roughly 0.17% to 2% of all dermoid cysts [1].

However, this small risk is noticeably higher in postmenopausal women than in younger women [2]. Studies show that warning signs for a cancerous change include postmenopausal status, a cyst that is large (often over 10 centimeters), and rapid growth or new solid components on an ultrasound [3] [4]. Because imaging tests cannot always perfectly distinguish between a complex benign cyst and a cancerous one, doctors often lean toward surgically removing dermoids in postmenopausal women, especially if they are large or symptomatic [5].

Observation vs. Surgery

Not every cyst requires immediate surgery. If your dermoid cyst is small, shows classic benign features on an ultrasound, and is not causing you any pain or symptoms, you and your doctor might choose structured observation [6].

  • Observation involves regular check-ups and repeat ultrasounds (often starting at 3 to 6 months, and then yearly) to ensure the cyst is not growing or developing concerning features [7].
  • Surgery is generally recommended if the cyst is causing symptoms (like pain, bloating, or feeling full quickly), is growing, or shows suspicious features on imaging [8].

Surgical Options

When surgery is chosen, the approach for a postmenopausal woman focuses on safety and definitive diagnosis.

  • Removing the Ovary and Tube: In younger women, surgeons try to perform a cystectomy (removing just the cyst) to preserve fertility. After menopause, the standard recommendation is often a salpingo-oophorectomy (removal of the entire ovary and its attached fallopian tube) [9]. Removing the whole structure helps avoid spilling the cyst’s contents into the pelvis and ensures no microscopic pieces of the cyst are left behind to regrow [10].
  • Removing Both Ovaries: Your doctor may discuss a bilateral salpingo-oophorectomy—removing both ovaries and fallopian tubes. This decision is not automatically required for a one-sided, benign-appearing cyst. It should be based on your personal preference, your hereditary risk for breast or ovarian cancer, the appearance of the other ovary, and a discussion of the potential long-term effects that removing both ovaries can have on your cardiovascular and bone health, even after menopause [11].

Ultimately, the only way to definitively confirm whether a mass is a benign dermoid or contains cancer is through surgical pathology, where a specialist examines the removed tissue under a microscope [12].

The Role (and Limits) of Blood Tests

Your doctor may order blood tests called tumor markers, such as CA-125 or SCC antigen (squamous cell carcinoma antigen), to help evaluate your overall risk.

It is important to know that these tests are helpful clues, but they are not definitive proof of cancer or benignity:

  • They can be falsely alarming: CA-125 is a common initial test, but it can be elevated due to completely benign reasons, or by the benign dermoid cyst itself [13].
  • They can be falsely reassuring: SCC antigen is a more specific test sometimes used for dermoids, but a normal CA-125 or SCC antigen result does not guarantee the cyst is completely benign. There are reports of postmenopausal women with cancerous changes in their cysts who had completely normal tumor marker levels [14] [3].

These markers are most useful when combined with your age, symptoms, and a formal ultrasound risk assessment [15].

When to See a Gynecologic Oncologist

If your overall assessment is suspicious—such as an ultrasound showing fixed solid nodules, ascites (fluid in the abdomen), or highly abnormal risk scores—your doctor should refer you to a gynecologic oncologist before surgery [16] [17].

A gynecologic oncologist specializes in cancers of the female reproductive system. Having this specialist perform or supervise the surgery ensures that if cancer is unexpectedly found, the appropriate staging and specialized surgical techniques can be performed safely during the same operation.

Urgent Symptoms to Watch For

Whether you are observing the cyst or waiting for surgery, seek immediate medical attention if you experience sudden, severe abdominal or pelvic pain, especially if it is accompanied by nausea, vomiting, fever, or faintness. These can be signs of a rare but serious emergency, such as the cyst twisting on its blood supply (torsion) or bursting (rupture), which require urgent surgical care [10] [18].

Common questions in this guide

What are the treatment choices for an ovarian dermoid cyst after menopause?
Treatment may involve structured observation with repeat ultrasounds or surgery. Doctors consider the cyst’s size, ultrasound appearance, symptoms, growth, and your overall health; surgery is often favored when the cyst is large, symptomatic, or suspicious.
Can a dermoid cyst be watched instead of removed after menopause?
Yes, a small cyst with classic benign ultrasound features and no symptoms may be monitored rather than removed. Follow-up often begins with another ultrasound in 3 to 6 months and then continues yearly, although the exact schedule is individualized.
What does surgery usually involve after menopause?
When surgery is chosen, doctors often remove the affected ovary and fallopian tube together, a procedure called salpingo-oophorectomy, rather than removing only the cyst. Removing the whole structure can help avoid spilling cyst contents and leaving behind tissue that could regrow.
Do normal CA-125 or SCC antigen results rule out cancer in a dermoid cyst?
No. These blood tests provide clues, but a normal CA-125 or SCC antigen level cannot guarantee that a cyst is benign; results must be interpreted with symptoms, imaging, and age.
Will both ovaries need to be removed?
Not necessarily. For a one-sided cyst that looks benign, removal of the affected ovary and tube may be considered; removing both depends on hereditary cancer risk, the other ovary’s appearance, your preferences, and discussion of long-term health effects.
When should I see a gynecologic oncologist for a dermoid cyst?
Referral is appropriate when imaging shows fixed solid nodules, fluid in the abdomen, or a highly abnormal risk score, or when cancer is otherwise suspected. A gynecologic oncologist can plan surgery and cancer staging if malignant cells are found.
What symptoms from a postmenopausal dermoid cyst require urgent care?
Seek immediate medical attention for sudden, severe abdominal or pelvic pain, especially with nausea, vomiting, fever, or faintness. These symptoms can signal twisting of the ovary or rupture of the cyst, which may require urgent surgery.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on dermoid cyst.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my ultrasound show a classic benign dermoid, or are there complex features that require a specialist's opinion?
  2. 2.Based on my age, symptoms, and ultrasound, do you recommend surgery or structured observation?
  3. 3.If we choose observation, what is the exact schedule for my follow-up ultrasounds, and what changes would prompt us to reconsider surgery?
  4. 4.If surgery is recommended, will you plan to remove just the ovary and tube on that side, or both? How does my family history impact this decision?
  5. 5.What is the plan if the surgical pathology unexpectedly shows malignant cells?
  6. 6.Are you recommending any tumor marker blood tests, and how will those results actually change our treatment plan?

References

References (18)
  1. 1

    Rare Case of Sarcomatoid Squamous Cell Carcinoma Arising in an Ovarian Mature Teratoma.

    Pedrosa ISS, Alpendre FDCA, Sousa R, et al.

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2019; (41(10)):628-632 doi:10.1055/s-0039-1698773.

    PMID: 31658491
  2. 2

    Malignant transformation arising from mature ovarian cystic teratoma: A case series.

    Qin L, Zhao T, Liu X, et al.

    Medicine 2021; (100(13)):e24726 doi:10.1097/MD.0000000000024726.

    PMID: 33787574
  3. 3

    Malignant Transformation of Squamous Cell Carcinoma in Mature Cystic Teratoma of the Ovary: A Systematic Review and Meta-Analysis of Data.

    Wu SY, Giannini A, Girardo M, et al.

    Gynecologic and obstetric investigation 2025; (90(3)):255-267 doi:10.1159/000542672.

    PMID: 39561732
  4. 4

    Squamous cell carcinoma arising within a mature cystic teratoma of the ovary in a postmenopausal woman: A case report and literature review.

    Bahall V, Bhagaloo V, De Barry L, et al.

    Case reports in women's health 2026; (50()):e00803 doi:10.1016/j.crwh.2026.e00803.

    PMID: 41939179
  5. 5

    First International Consensus Report on Adnexal Masses: Management Recommendations.

    Glanc P, Benacerraf B, Bourne T, et al.

    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2017; (36(5)):849-863 doi:10.1002/jum.14197.

    PMID: 28266033
  6. 6

    Natural history and malignant potential of simple ovarian cysts in postmenopausal women: a systematic review and meta-analysis.

    Liu YN, Tan X, Xiong W, et al.

    Menopause (New York, N.Y.) 2023; (30(5)):559-565 doi:10.1097/GME.0000000000002163.

    PMID: 36787526
  7. 7

    Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study.

    Froyman W, Landolfo C, De Cock B, et al.

    The Lancet. Oncology 2019; (20(3)):448-458 doi:10.1016/S1470-2045(18)30837-4.

    PMID: 30737137
  8. 8

    A rare case of squamous cell carcinoma transformation in a mature cystic teratoma of the ovary.

    Sibarani CNR, Permata HD, Martiana EF, et al.

    SAGE open medical case reports 2023; (11()):2050313X231193305 doi:10.1177/2050313X231193305.

    PMID: 37581115
  9. 9

    Ovarian Mature Cystic Teratoma: Challenges of Surgical Management.

    Sinha A, Ewies AA

    Obstetrics and gynecology international 2016; (2016()):2390178 doi:10.1155/2016/2390178.

    PMID: 27110246
  10. 10

    Chemical peritonitis resulting from spontaneous rupture of a mature ovarian cystic teratoma: a case report.

    Bužinskienė D, Mongirdas M, Mikėnas S, et al.

    Acta medica Lituanic 2019; (26(4)):217-226 doi:10.6001/actamedica.v26i4.4207.

    PMID: 32355460
  11. 11

    The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women.

    Chen IJ, Shoupe D, Karim R, et al.

    Menopause (New York, N.Y.) 2023; (30(7)):692-702 doi:10.1097/GME.0000000000002192.

    PMID: 37192828
  12. 12

    A rare case of malignant transformation: squamous cell carcinoma arising on the basis of an ovarian mature cystic teratoma.

    Özdem F, Kaymak SD, Turhan B, et al.

    BMC women's health 2025; (25(1)):213 doi:10.1186/s12905-025-03755-7.

    PMID: 40316993
  13. 13

    Elevated CA 125 level in a mucinous cystadenoma and a teratoma: a case report.

    Ekanayake CD, Munasinghe N, Kumarasinghe I, Rasnayake S

    Journal of medical case reports 2020; (14(1)):141 doi:10.1186/s13256-020-02458-x.

    PMID: 32878645
  14. 14

    Malignancy Arising in Dermoid Cysts: A Case Report and Literature Review.

    Arab M, Ashtiani AJ, Faghih N, et al.

    Journal of family & reproductive health 2023; (17(4)):264-268 doi:10.18502/jfrh.v17i4.14599.

    PMID: 38807623
  15. 15

    A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.

    Lycke M, Kristjansdottir B, Sundfeldt K

    Gynecologic oncology 2018; (151(1)):159-165 doi:10.1016/j.ygyno.2018.08.025.

    PMID: 30149898
  16. 16

    Adnexal Masses: Diagnosis and Management.

    Wheeler V, Umstead B, Chadwick C

    American family physician 2023; (108(6)):580-587.

    PMID: 38215419
  17. 17

    Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.

    Timmerman D, Van Calster B, Testa A, et al.

    American journal of obstetrics and gynecology 2016; (214(4)):424-437 doi:10.1016/j.ajog.2016.01.007.

    PMID: 26800772
  18. 18

    Spontaneously Ruptured Dermoid Cysts and Their Potential Complications: A Review of the Literature with a Case Report.

    Li RY, Nikam Y, Kapurubandara S

    Case reports in obstetrics and gynecology 2020; (2020()):6591280 doi:10.1155/2020/6591280.

    PMID: 32292616

This page explains treatment choices for an ovarian dermoid cyst after menopause for informational purposes only and does not constitute medical advice. Discuss your imaging, symptoms, and surgical options with your gynecologist.